khk7791
Showing 1 - 7 of 7
Hyperphosphatemia Trial in Suita (KHK7791)
Completed
- Hyperphosphatemia
- KHK7791
-
Suita, Osaka, JapanInoue Hospital
Jan 7, 2022
Hyperphosphatemia Trial in Suita (KHK7791, Placebo)
Completed
- Hyperphosphatemia
- KHK7791
- Placebo
-
Suita, Osaka, JapanInoue Hospital
Oct 26, 2021
Hyperphosphatemia Trial in Kanoya (KHK7791)
Active, not recruiting
- Hyperphosphatemia
- KHK7791
-
Kanoya, Kagoshima, JapanMedical Corporation Seijinkai Ikeda Hospital
Sep 7, 2021
Hyperphosphatemia Trial in Tsukuba (KHK7791, Placebo)
Completed
- Hyperphosphatemia
- KHK7791
- Placebo
-
Tsukuba, Ibaraki, JapanKikuchi medical clinic
Sep 7, 2021
Hyperphosphatemia Trial in Nagoya (KHK7791, Placebo)
Completed
- Hyperphosphatemia
- KHK7791
- Placebo
-
Nagoya, JapanStudy Site 1
Jan 14, 2020
Hyperphosphatemia Trial in Niigata (KHK7791)
Completed
- Hyperphosphatemia
- KHK7791
-
Niigata, JapanStudy Site 1
Jan 14, 2020